AU2020903780A0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
AU2020903780A0
AU2020903780A0 AU2020903780A AU2020903780A AU2020903780A0 AU 2020903780 A0 AU2020903780 A0 AU 2020903780A0 AU 2020903780 A AU2020903780 A AU 2020903780A AU 2020903780 A AU2020903780 A AU 2020903780A AU 2020903780 A0 AU2020903780 A0 AU 2020903780A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020903780A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avecho Biotechnology Ltd
Original Assignee
Avecho Biotechnology Ltd
Filing date
Publication date
Application filed by Avecho Biotechnology Ltd filed Critical Avecho Biotechnology Ltd
Publication of AU2020903780A0 publication Critical patent/AU2020903780A0/en
Priority to CN202180084972.1A priority Critical patent/CN116583272A/en
Priority to CA3195937A priority patent/CA3195937A1/en
Priority to PCT/AU2021/051211 priority patent/WO2022082256A1/en
Priority to US18/249,632 priority patent/US20230381207A1/en
Priority to JP2023547723A priority patent/JP2023546267A/en
Priority to IL302160A priority patent/IL302160A/en
Priority to EP21881369.9A priority patent/EP4228612A1/en
Pending legal-status Critical Current

Links

AU2020903780A 2020-10-19 2020-10-19 Pharmaceutical formulations Pending AU2020903780A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN202180084972.1A CN116583272A (en) 2020-10-19 2021-10-18 Oral cannabinoid formulations comprising tocopherol phosphate and long chain triglycerides or long chain fatty acids
CA3195937A CA3195937A1 (en) 2020-10-19 2021-10-18 Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids
PCT/AU2021/051211 WO2022082256A1 (en) 2020-10-19 2021-10-18 Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids
US18/249,632 US20230381207A1 (en) 2020-10-19 2021-10-18 Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids
JP2023547723A JP2023546267A (en) 2020-10-19 2021-10-18 Oral cannabinoid preparations comprising tocopheryl phosphate and long chain triglycerides or long chain fatty acids
IL302160A IL302160A (en) 2020-10-19 2021-10-18 Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids
EP21881369.9A EP4228612A1 (en) 2020-10-19 2021-10-18 Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids

Publications (1)

Publication Number Publication Date
AU2020903780A0 true AU2020903780A0 (en) 2020-11-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP4045480A4 (en) Pharmaceutical formulations
EP4149470A4 (en) Pharmaceutical formulations and uses thereof
EP3946316A4 (en) Cannabidiol pharmaceutical compositions
EP4028059A4 (en) Stable medicinal cannabidiol compositions
EP4135699A4 (en) Pharmaceutical compositions
EP4122483A4 (en) Oral pharmaceutical composition
EP4015001A4 (en) Oral pharmaceutical composition
EP4048276A4 (en) Solid pharmaceutical formulations comprising ticagrelor
GB202010230D0 (en) Pharmaceutical formulation
EP3946296A4 (en) Extended release pharmaceutical formulation
EP4058025A4 (en) Pharmaceutical compositions comprising ticagrelor
EP4190310A4 (en) Stable pharmaceutical preparation
EP4197540A4 (en) Drug formulation containing sepetaprost
EP4081251A4 (en) Pharmaceutical compositions
EP3914234A4 (en) Pharmaceutical compositions
EP3746080A4 (en) Pharmaceutical formulations
AU2020903781A0 (en) Pharmaceutical formulations
AU2020903780A0 (en) Pharmaceutical formulations
TWI848533B (en) Ribociclib pharmaceutical compositions
AU2023221615A1 (en) Pharmaceutical formulation
EP4205765A4 (en) Stable pharmaceutical preparation
TWI800878B (en) Drug set
ZA202212663B (en) Pharmaceutical formulations
IL308250A (en) Pharmaceutical formulations
GB202112820D0 (en) Pharmaceutical formulations